DOI: 10.1002/ccr3.73279 ISSN: 2050-0904
A Case Report of a Patient With Recalcitrant Pemphigus Vulgaris Treated With Rituximab
Mahlatse Cordelia Kgokolo, Lesedi Makgwethele Nevondo, Michaela Beetge, Razia A. G. KhammissaABSTRACT
Pemphigus vulgaris may demonstrate differential treatment responses across disease sites. In this case, cutaneous lesions responded to high‐dose corticosteroids, whereas refractory oral disease required rituximab to achieve remission, highlighting the need for individualized, multimodal therapy to achieve sustained disease control.